These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25664025)

  • 1. Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.
    Lin MS; Chen WC; Huang JX; Gao HJ; Sheng HH
    Int J Clin Exp Med; 2014; 7(12):5226-34. PubMed ID: 25664025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer.
    Wei J; Yang L; Wu YN; Xu J
    J Cancer; 2020; 11(6):1325-1333. PubMed ID: 32047539
    [No Abstract]   [Full Text] [Related]  

  • 3. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-629 is a novel molecular marker for diagnosis and the prognosis of pancreatic cancer.
    Shi W; Lu Y; Gong R; Sun JJ; Liu G
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5187-5193. PubMed ID: 30178840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC).
    Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M
    Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
    Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
    Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
    Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
    J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
    Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
    Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
    Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker.
    Al-Kafaji G; Al-Naieb ZT; Bakhiet M
    Oncol Lett; 2016 Feb; 11(2):1201-1206. PubMed ID: 26893719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?].
    Škrha P; Hořínek A; Anděl M; Škrha J
    Vnitr Lek; 2015 Apr; 61(4):351-4. PubMed ID: 25894267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
    Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
    Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.
    Han JG; Jiang YD; Zhang CH; Yang YM; Pang D; Song YN; Zhang GQ
    Ann Surg Treat Res; 2017 Feb; 92(2):55-66. PubMed ID: 28203552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.
    Ganepola GA; Rutledge JR; Suman P; Yiengpruksawan A; Chang DH
    World J Gastrointest Oncol; 2014 Jan; 6(1):22-33. PubMed ID: 24578785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.